Brave steps to USA project co-funded by European Union (EU)

Expansion of the RegJoint™ small joint implant to markets of the North America follows our strategy for the significant entrance to new markets, beyond European Union. The initiation of FDA market approval process requires strengthening of our production capabilities, validation of the production methods and the related testing. Parallel with these activities we are seeking for the appropriate partners for distribution and delivery in North America, including USA and Canada.

We are thankful for European Union for EAKR funding, which accelerates our steps towards these goals.